nodes	percent_of_prediction	percent_of_DWPC	metapath
Zafirlukast—ABCG2—Conjugated Estrogens—osteoporosis	0.0623	0.0882	CbGbCtD
Zafirlukast—ABCG2—Estradiol—osteoporosis	0.0547	0.0775	CbGbCtD
Zafirlukast—CYP1A2—Estropipate—osteoporosis	0.0543	0.0769	CbGbCtD
Zafirlukast—CYP2C9—Estropipate—osteoporosis	0.0489	0.0693	CbGbCtD
Zafirlukast—CYP2C8—Raloxifene—osteoporosis	0.0468	0.0663	CbGbCtD
Zafirlukast—CYP2C8—Ethinyl Estradiol—osteoporosis	0.0452	0.064	CbGbCtD
Zafirlukast—CYP2C8—Cholecalciferol—osteoporosis	0.0361	0.0512	CbGbCtD
Zafirlukast—CYP2C19—Cholecalciferol—osteoporosis	0.0303	0.0429	CbGbCtD
Zafirlukast—CYP2C8—Estradiol—osteoporosis	0.0291	0.0413	CbGbCtD
Zafirlukast—CYP3A4—Estropipate—osteoporosis	0.0284	0.0403	CbGbCtD
Zafirlukast—CYP3A4—Calcitriol—osteoporosis	0.0284	0.0403	CbGbCtD
Zafirlukast—CYP1A2—Conjugated Estrogens—osteoporosis	0.0257	0.0364	CbGbCtD
Zafirlukast—CYP2C9—Cholecalciferol—osteoporosis	0.0252	0.0357	CbGbCtD
Zafirlukast—CYP2C19—Estradiol—osteoporosis	0.0244	0.0346	CbGbCtD
Zafirlukast—CYP2D6—Cholecalciferol—osteoporosis	0.023	0.0327	CbGbCtD
Zafirlukast—CYP3A4—Ergocalciferol—osteoporosis	0.0227	0.0322	CbGbCtD
Zafirlukast—CYP1A2—Estradiol—osteoporosis	0.0225	0.0319	CbGbCtD
Zafirlukast—CYP2C9—Estradiol—osteoporosis	0.0203	0.0288	CbGbCtD
Zafirlukast—CYP3A4—Raloxifene—osteoporosis	0.019	0.0269	CbGbCtD
Zafirlukast—CYP3A4—Ethinyl Estradiol—osteoporosis	0.0183	0.026	CbGbCtD
Zafirlukast—CYP3A4—Cholecalciferol—osteoporosis	0.0147	0.0208	CbGbCtD
Zafirlukast—CYP3A4—Conjugated Estrogens—osteoporosis	0.0135	0.0191	CbGbCtD
Zafirlukast—CYP3A4—Estradiol—osteoporosis	0.0118	0.0167	CbGbCtD
Zafirlukast—Dyspepsia—Raloxifene—osteoporosis	0.000495	0.00215	CcSEcCtD
Zafirlukast—Hypersensitivity—Etidronic acid—osteoporosis	0.000495	0.00215	CcSEcCtD
Zafirlukast—Insomnia—Calcitriol—osteoporosis	0.000493	0.00214	CcSEcCtD
Zafirlukast—Dyspepsia—Ibandronate—osteoporosis	0.00049	0.00213	CcSEcCtD
Zafirlukast—Pain—Alendronate—osteoporosis	0.000489	0.00213	CcSEcCtD
Zafirlukast—Angioedema—Pamidronate—osteoporosis	0.000489	0.00212	CcSEcCtD
Zafirlukast—Gastrointestinal disorder—Raloxifene—osteoporosis	0.000486	0.00211	CcSEcCtD
Zafirlukast—Discomfort—Ethinyl Estradiol—osteoporosis	0.000485	0.00211	CcSEcCtD
Zafirlukast—Malaise—Pamidronate—osteoporosis	0.000482	0.0021	CcSEcCtD
Zafirlukast—Pain—Raloxifene—osteoporosis	0.000481	0.00209	CcSEcCtD
Zafirlukast—Gastrointestinal disorder—Ibandronate—osteoporosis	0.000481	0.00209	CcSEcCtD
Zafirlukast—Fatigue—Ibandronate—osteoporosis	0.00048	0.00209	CcSEcCtD
Zafirlukast—Arthralgia—Risedronate—osteoporosis	0.000479	0.00208	CcSEcCtD
Zafirlukast—Myalgia—Risedronate—osteoporosis	0.000479	0.00208	CcSEcCtD
Zafirlukast—Pain—Ibandronate—osteoporosis	0.000476	0.00207	CcSEcCtD
Zafirlukast—Pruritus—Etidronic acid—osteoporosis	0.000475	0.00206	CcSEcCtD
Zafirlukast—Gastrointestinal pain—Estropipate—osteoporosis	0.000475	0.00206	CcSEcCtD
Zafirlukast—Back pain—Zoledronate—osteoporosis	0.000472	0.00205	CcSEcCtD
Zafirlukast—Neuropathy peripheral—Estradiol—osteoporosis	0.000472	0.00205	CcSEcCtD
Zafirlukast—Feeling abnormal—Alendronate—osteoporosis	0.000471	0.00205	CcSEcCtD
Zafirlukast—Oedema—Ethinyl Estradiol—osteoporosis	0.000471	0.00205	CcSEcCtD
Zafirlukast—Jaundice—Estradiol—osteoporosis	0.000469	0.00204	CcSEcCtD
Zafirlukast—Gastrointestinal pain—Alendronate—osteoporosis	0.000468	0.00203	CcSEcCtD
Zafirlukast—Infection—Ethinyl Estradiol—osteoporosis	0.000468	0.00203	CcSEcCtD
Zafirlukast—Pain—Calcitriol—osteoporosis	0.000466	0.00203	CcSEcCtD
Zafirlukast—Urticaria—Estropipate—osteoporosis	0.000461	0.00201	CcSEcCtD
Zafirlukast—Gastrointestinal pain—Raloxifene—osteoporosis	0.00046	0.002	CcSEcCtD
Zafirlukast—Diarrhoea—Etidronic acid—osteoporosis	0.000459	0.002	CcSEcCtD
Zafirlukast—Abdominal pain—Estropipate—osteoporosis	0.000459	0.002	CcSEcCtD
Zafirlukast—Body temperature increased—Estropipate—osteoporosis	0.000459	0.002	CcSEcCtD
Zafirlukast—Feeling abnormal—Ibandronate—osteoporosis	0.000459	0.002	CcSEcCtD
Zafirlukast—Infection—Risedronate—osteoporosis	0.000456	0.00198	CcSEcCtD
Zafirlukast—Gastrointestinal pain—Ibandronate—osteoporosis	0.000455	0.00198	CcSEcCtD
Zafirlukast—Arthralgia—Pamidronate—osteoporosis	0.000455	0.00198	CcSEcCtD
Zafirlukast—Myalgia—Pamidronate—osteoporosis	0.000455	0.00198	CcSEcCtD
Zafirlukast—Back pain—Conjugated Estrogens—osteoporosis	0.000455	0.00198	CcSEcCtD
Zafirlukast—Urticaria—Alendronate—osteoporosis	0.000455	0.00198	CcSEcCtD
Zafirlukast—Ill-defined disorder—Zoledronate—osteoporosis	0.000453	0.00197	CcSEcCtD
Zafirlukast—Body temperature increased—Alendronate—osteoporosis	0.000452	0.00197	CcSEcCtD
Zafirlukast—Abdominal pain—Alendronate—osteoporosis	0.000452	0.00197	CcSEcCtD
Zafirlukast—Sinusitis—Estradiol—osteoporosis	0.000452	0.00196	CcSEcCtD
Zafirlukast—Discomfort—Pamidronate—osteoporosis	0.00045	0.00195	CcSEcCtD
Zafirlukast—Angioedema—Zoledronate—osteoporosis	0.000446	0.00194	CcSEcCtD
Zafirlukast—Gastrointestinal pain—Calcitriol—osteoporosis	0.000446	0.00194	CcSEcCtD
Zafirlukast—Abdominal pain—Raloxifene—osteoporosis	0.000445	0.00193	CcSEcCtD
Zafirlukast—Body temperature increased—Raloxifene—osteoporosis	0.000445	0.00193	CcSEcCtD
Zafirlukast—Urticaria—Ibandronate—osteoporosis	0.000443	0.00192	CcSEcCtD
Zafirlukast—Malaise—Zoledronate—osteoporosis	0.00044	0.00191	CcSEcCtD
Zafirlukast—Abdominal pain—Ibandronate—osteoporosis	0.00044	0.00191	CcSEcCtD
Zafirlukast—Body temperature increased—Ibandronate—osteoporosis	0.00044	0.00191	CcSEcCtD
Zafirlukast—Oedema—Pamidronate—osteoporosis	0.000436	0.0019	CcSEcCtD
Zafirlukast—Haemoglobin—Estradiol—osteoporosis	0.000435	0.00189	CcSEcCtD
Zafirlukast—Infection—Pamidronate—osteoporosis	0.000434	0.00188	CcSEcCtD
Zafirlukast—Urticaria—Calcitriol—osteoporosis	0.000433	0.00188	CcSEcCtD
Zafirlukast—Hepatitis—Estradiol—osteoporosis	0.000432	0.00188	CcSEcCtD
Zafirlukast—Haemorrhage—Estradiol—osteoporosis	0.000432	0.00188	CcSEcCtD
Zafirlukast—Abdominal pain—Calcitriol—osteoporosis	0.000431	0.00187	CcSEcCtD
Zafirlukast—Body temperature increased—Calcitriol—osteoporosis	0.000431	0.00187	CcSEcCtD
Zafirlukast—Hypoaesthesia—Estradiol—osteoporosis	0.00043	0.00187	CcSEcCtD
Zafirlukast—Angioedema—Conjugated Estrogens—osteoporosis	0.00043	0.00187	CcSEcCtD
Zafirlukast—Hypersensitivity—Estropipate—osteoporosis	0.000428	0.00186	CcSEcCtD
Zafirlukast—Thrombocytopenia—Pamidronate—osteoporosis	0.000427	0.00186	CcSEcCtD
Zafirlukast—Vomiting—Etidronic acid—osteoporosis	0.000427	0.00186	CcSEcCtD
Zafirlukast—Rash—Etidronic acid—osteoporosis	0.000423	0.00184	CcSEcCtD
Zafirlukast—Dermatitis—Etidronic acid—osteoporosis	0.000423	0.00184	CcSEcCtD
Zafirlukast—Hypersensitivity—Alendronate—osteoporosis	0.000422	0.00183	CcSEcCtD
Zafirlukast—Headache—Etidronic acid—osteoporosis	0.000421	0.00183	CcSEcCtD
Zafirlukast—Musculoskeletal discomfort—Risedronate—osteoporosis	0.000418	0.00182	CcSEcCtD
Zafirlukast—Asthenia—Estropipate—osteoporosis	0.000417	0.00181	CcSEcCtD
Zafirlukast—Arthralgia—Zoledronate—osteoporosis	0.000416	0.00181	CcSEcCtD
Zafirlukast—Myalgia—Zoledronate—osteoporosis	0.000416	0.00181	CcSEcCtD
Zafirlukast—Insomnia—Risedronate—osteoporosis	0.000415	0.0018	CcSEcCtD
Zafirlukast—Pruritus—Estropipate—osteoporosis	0.000411	0.00179	CcSEcCtD
Zafirlukast—Discomfort—Zoledronate—osteoporosis	0.000411	0.00179	CcSEcCtD
Zafirlukast—Asthenia—Alendronate—osteoporosis	0.00041	0.00178	CcSEcCtD
Zafirlukast—Hypersensitivity—Ibandronate—osteoporosis	0.00041	0.00178	CcSEcCtD
Zafirlukast—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.000406	0.00177	CcSEcCtD
Zafirlukast—Fatigue—Ethinyl Estradiol—osteoporosis	0.000406	0.00176	CcSEcCtD
Zafirlukast—Pruritus—Alendronate—osteoporosis	0.000405	0.00176	CcSEcCtD
Zafirlukast—Dyspepsia—Risedronate—osteoporosis	0.000404	0.00176	CcSEcCtD
Zafirlukast—Hypersensitivity—Calcitriol—osteoporosis	0.000402	0.00175	CcSEcCtD
Zafirlukast—Arthralgia—Conjugated Estrogens—osteoporosis	0.0004	0.00174	CcSEcCtD
Zafirlukast—Myalgia—Conjugated Estrogens—osteoporosis	0.0004	0.00174	CcSEcCtD
Zafirlukast—Asthenia—Ibandronate—osteoporosis	0.0004	0.00174	CcSEcCtD
Zafirlukast—Nausea—Etidronic acid—osteoporosis	0.000399	0.00173	CcSEcCtD
Zafirlukast—Oedema—Zoledronate—osteoporosis	0.000399	0.00173	CcSEcCtD
Zafirlukast—Musculoskeletal discomfort—Pamidronate—osteoporosis	0.000398	0.00173	CcSEcCtD
Zafirlukast—Diarrhoea—Estropipate—osteoporosis	0.000397	0.00173	CcSEcCtD
Zafirlukast—Gastrointestinal disorder—Risedronate—osteoporosis	0.000396	0.00172	CcSEcCtD
Zafirlukast—Infection—Zoledronate—osteoporosis	0.000396	0.00172	CcSEcCtD
Zafirlukast—Fatigue—Risedronate—osteoporosis	0.000396	0.00172	CcSEcCtD
Zafirlukast—Insomnia—Pamidronate—osteoporosis	0.000395	0.00172	CcSEcCtD
Zafirlukast—Pruritus—Ibandronate—osteoporosis	0.000394	0.00171	CcSEcCtD
Zafirlukast—Pain—Risedronate—osteoporosis	0.000393	0.00171	CcSEcCtD
Zafirlukast—Diarrhoea—Alendronate—osteoporosis	0.000391	0.0017	CcSEcCtD
Zafirlukast—Asthenia—Calcitriol—osteoporosis	0.000391	0.0017	CcSEcCtD
Zafirlukast—Thrombocytopenia—Zoledronate—osteoporosis	0.00039	0.0017	CcSEcCtD
Zafirlukast—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.000388	0.00169	CcSEcCtD
Zafirlukast—Pruritus—Calcitriol—osteoporosis	0.000386	0.00168	CcSEcCtD
Zafirlukast—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.000385	0.00167	CcSEcCtD
Zafirlukast—Diarrhoea—Raloxifene—osteoporosis	0.000385	0.00167	CcSEcCtD
Zafirlukast—Dyspepsia—Pamidronate—osteoporosis	0.000384	0.00167	CcSEcCtD
Zafirlukast—Dizziness—Estropipate—osteoporosis	0.000384	0.00167	CcSEcCtD
Zafirlukast—Oedema—Conjugated Estrogens—osteoporosis	0.000384	0.00167	CcSEcCtD
Zafirlukast—Infection—Conjugated Estrogens—osteoporosis	0.000381	0.00166	CcSEcCtD
Zafirlukast—Diarrhoea—Ibandronate—osteoporosis	0.000381	0.00166	CcSEcCtD
Zafirlukast—Dizziness—Alendronate—osteoporosis	0.000378	0.00164	CcSEcCtD
Zafirlukast—Gastrointestinal disorder—Pamidronate—osteoporosis	0.000377	0.00164	CcSEcCtD
Zafirlukast—Fatigue—Pamidronate—osteoporosis	0.000376	0.00164	CcSEcCtD
Zafirlukast—Gastrointestinal pain—Risedronate—osteoporosis	0.000375	0.00163	CcSEcCtD
Zafirlukast—Urticaria—Ethinyl Estradiol—osteoporosis	0.000374	0.00163	CcSEcCtD
Zafirlukast—Pain—Pamidronate—osteoporosis	0.000373	0.00162	CcSEcCtD
Zafirlukast—Diarrhoea—Calcitriol—osteoporosis	0.000373	0.00162	CcSEcCtD
Zafirlukast—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.000372	0.00162	CcSEcCtD
Zafirlukast—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.000372	0.00162	CcSEcCtD
Zafirlukast—Dizziness—Raloxifene—osteoporosis	0.000372	0.00162	CcSEcCtD
Zafirlukast—Vomiting—Estropipate—osteoporosis	0.000369	0.00161	CcSEcCtD
Zafirlukast—Dizziness—Ibandronate—osteoporosis	0.000368	0.0016	CcSEcCtD
Zafirlukast—Rash—Estropipate—osteoporosis	0.000366	0.00159	CcSEcCtD
Zafirlukast—Dermatitis—Estropipate—osteoporosis	0.000366	0.00159	CcSEcCtD
Zafirlukast—Urticaria—Risedronate—osteoporosis	0.000365	0.00159	CcSEcCtD
Zafirlukast—Back pain—Estradiol—osteoporosis	0.000364	0.00158	CcSEcCtD
Zafirlukast—Headache—Estropipate—osteoporosis	0.000364	0.00158	CcSEcCtD
Zafirlukast—Vomiting—Alendronate—osteoporosis	0.000364	0.00158	CcSEcCtD
Zafirlukast—Musculoskeletal discomfort—Zoledronate—osteoporosis	0.000363	0.00158	CcSEcCtD
Zafirlukast—Abdominal pain—Risedronate—osteoporosis	0.000363	0.00158	CcSEcCtD
Zafirlukast—Body temperature increased—Risedronate—osteoporosis	0.000363	0.00158	CcSEcCtD
Zafirlukast—Rash—Alendronate—osteoporosis	0.000361	0.00157	CcSEcCtD
Zafirlukast—Insomnia—Zoledronate—osteoporosis	0.000361	0.00157	CcSEcCtD
Zafirlukast—Dermatitis—Alendronate—osteoporosis	0.00036	0.00157	CcSEcCtD
Zafirlukast—Feeling abnormal—Pamidronate—osteoporosis	0.00036	0.00156	CcSEcCtD
Zafirlukast—Headache—Alendronate—osteoporosis	0.000358	0.00156	CcSEcCtD
Zafirlukast—Vomiting—Raloxifene—osteoporosis	0.000358	0.00155	CcSEcCtD
Zafirlukast—Gastrointestinal pain—Pamidronate—osteoporosis	0.000357	0.00155	CcSEcCtD
Zafirlukast—Rash—Raloxifene—osteoporosis	0.000355	0.00154	CcSEcCtD
Zafirlukast—Dermatitis—Raloxifene—osteoporosis	0.000354	0.00154	CcSEcCtD
Zafirlukast—Vomiting—Ibandronate—osteoporosis	0.000354	0.00154	CcSEcCtD
Zafirlukast—Headache—Raloxifene—osteoporosis	0.000352	0.00153	CcSEcCtD
Zafirlukast—Rash—Ibandronate—osteoporosis	0.000351	0.00153	CcSEcCtD
Zafirlukast—Dermatitis—Ibandronate—osteoporosis	0.000351	0.00153	CcSEcCtD
Zafirlukast—Dyspepsia—Zoledronate—osteoporosis	0.000351	0.00153	CcSEcCtD
Zafirlukast—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	0.00035	0.00152	CcSEcCtD
Zafirlukast—Ill-defined disorder—Estradiol—osteoporosis	0.000349	0.00152	CcSEcCtD
Zafirlukast—Headache—Ibandronate—osteoporosis	0.000349	0.00152	CcSEcCtD
Zafirlukast—Insomnia—Conjugated Estrogens—osteoporosis	0.000347	0.00151	CcSEcCtD
Zafirlukast—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.000347	0.00151	CcSEcCtD
Zafirlukast—Vomiting—Calcitriol—osteoporosis	0.000347	0.00151	CcSEcCtD
Zafirlukast—Nausea—Estropipate—osteoporosis	0.000345	0.0015	CcSEcCtD
Zafirlukast—Abdominal pain—Pamidronate—osteoporosis	0.000345	0.0015	CcSEcCtD
Zafirlukast—Body temperature increased—Pamidronate—osteoporosis	0.000345	0.0015	CcSEcCtD
Zafirlukast—Gastrointestinal disorder—Zoledronate—osteoporosis	0.000344	0.0015	CcSEcCtD
Zafirlukast—Angioedema—Estradiol—osteoporosis	0.000344	0.00149	CcSEcCtD
Zafirlukast—Rash—Calcitriol—osteoporosis	0.000344	0.00149	CcSEcCtD
Zafirlukast—Fatigue—Zoledronate—osteoporosis	0.000344	0.00149	CcSEcCtD
Zafirlukast—Dermatitis—Calcitriol—osteoporosis	0.000343	0.00149	CcSEcCtD
Zafirlukast—Headache—Calcitriol—osteoporosis	0.000342	0.00148	CcSEcCtD
Zafirlukast—Pain—Zoledronate—osteoporosis	0.000341	0.00148	CcSEcCtD
Zafirlukast—Nausea—Alendronate—osteoporosis	0.00034	0.00148	CcSEcCtD
Zafirlukast—Malaise—Estradiol—osteoporosis	0.000339	0.00148	CcSEcCtD
Zafirlukast—Hypersensitivity—Risedronate—osteoporosis	0.000338	0.00147	CcSEcCtD
Zafirlukast—Dyspepsia—Conjugated Estrogens—osteoporosis	0.000338	0.00147	CcSEcCtD
Zafirlukast—Asthenia—Ethinyl Estradiol—osteoporosis	0.000338	0.00147	CcSEcCtD
Zafirlukast—Nausea—Raloxifene—osteoporosis	0.000334	0.00145	CcSEcCtD
Zafirlukast—Pruritus—Ethinyl Estradiol—osteoporosis	0.000333	0.00145	CcSEcCtD
Zafirlukast—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	0.000331	0.00144	CcSEcCtD
Zafirlukast—Fatigue—Conjugated Estrogens—osteoporosis	0.000331	0.00144	CcSEcCtD
Zafirlukast—Nausea—Ibandronate—osteoporosis	0.000331	0.00144	CcSEcCtD
Zafirlukast—Asthenia—Risedronate—osteoporosis	0.000329	0.00143	CcSEcCtD
Zafirlukast—Feeling abnormal—Zoledronate—osteoporosis	0.000328	0.00143	CcSEcCtD
Zafirlukast—Pain—Conjugated Estrogens—osteoporosis	0.000328	0.00143	CcSEcCtD
Zafirlukast—Gastrointestinal pain—Zoledronate—osteoporosis	0.000326	0.00142	CcSEcCtD
Zafirlukast—Pruritus—Risedronate—osteoporosis	0.000325	0.00141	CcSEcCtD
Zafirlukast—Nausea—Calcitriol—osteoporosis	0.000324	0.00141	CcSEcCtD
Zafirlukast—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000322	0.0014	CcSEcCtD
Zafirlukast—Hypersensitivity—Pamidronate—osteoporosis	0.000322	0.0014	CcSEcCtD
Zafirlukast—Myalgia—Estradiol—osteoporosis	0.00032	0.00139	CcSEcCtD
Zafirlukast—Arthralgia—Estradiol—osteoporosis	0.00032	0.00139	CcSEcCtD
Zafirlukast—Urticaria—Zoledronate—osteoporosis	0.000317	0.00138	CcSEcCtD
Zafirlukast—Discomfort—Estradiol—osteoporosis	0.000317	0.00138	CcSEcCtD
Zafirlukast—Body temperature increased—Zoledronate—osteoporosis	0.000315	0.00137	CcSEcCtD
Zafirlukast—Abdominal pain—Zoledronate—osteoporosis	0.000315	0.00137	CcSEcCtD
Zafirlukast—Diarrhoea—Risedronate—osteoporosis	0.000314	0.00137	CcSEcCtD
Zafirlukast—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.000314	0.00136	CcSEcCtD
Zafirlukast—Asthenia—Pamidronate—osteoporosis	0.000313	0.00136	CcSEcCtD
Zafirlukast—Dizziness—Ethinyl Estradiol—osteoporosis	0.000311	0.00135	CcSEcCtD
Zafirlukast—Pruritus—Pamidronate—osteoporosis	0.000309	0.00134	CcSEcCtD
Zafirlukast—Oedema—Estradiol—osteoporosis	0.000307	0.00134	CcSEcCtD
Zafirlukast—Infection—Estradiol—osteoporosis	0.000305	0.00133	CcSEcCtD
Zafirlukast—Urticaria—Conjugated Estrogens—osteoporosis	0.000305	0.00133	CcSEcCtD
Zafirlukast—Dizziness—Risedronate—osteoporosis	0.000304	0.00132	CcSEcCtD
Zafirlukast—Body temperature increased—Conjugated Estrogens—osteoporosis	0.000303	0.00132	CcSEcCtD
Zafirlukast—Abdominal pain—Conjugated Estrogens—osteoporosis	0.000303	0.00132	CcSEcCtD
Zafirlukast—Vomiting—Ethinyl Estradiol—osteoporosis	0.000299	0.0013	CcSEcCtD
Zafirlukast—Diarrhoea—Pamidronate—osteoporosis	0.000299	0.0013	CcSEcCtD
Zafirlukast—Rash—Ethinyl Estradiol—osteoporosis	0.000297	0.00129	CcSEcCtD
Zafirlukast—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000297	0.00129	CcSEcCtD
Zafirlukast—Headache—Ethinyl Estradiol—osteoporosis	0.000295	0.00128	CcSEcCtD
Zafirlukast—Hypersensitivity—Zoledronate—osteoporosis	0.000294	0.00128	CcSEcCtD
Zafirlukast—Vomiting—Risedronate—osteoporosis	0.000292	0.00127	CcSEcCtD
Zafirlukast—Rash—Risedronate—osteoporosis	0.000289	0.00126	CcSEcCtD
Zafirlukast—Dermatitis—Risedronate—osteoporosis	0.000289	0.00126	CcSEcCtD
Zafirlukast—Dizziness—Pamidronate—osteoporosis	0.000289	0.00125	CcSEcCtD
Zafirlukast—Headache—Risedronate—osteoporosis	0.000288	0.00125	CcSEcCtD
Zafirlukast—Asthenia—Zoledronate—osteoporosis	0.000286	0.00124	CcSEcCtD
Zafirlukast—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.000283	0.00123	CcSEcCtD
Zafirlukast—Pruritus—Zoledronate—osteoporosis	0.000282	0.00123	CcSEcCtD
Zafirlukast—Musculoskeletal discomfort—Estradiol—osteoporosis	0.00028	0.00122	CcSEcCtD
Zafirlukast—Nausea—Ethinyl Estradiol—osteoporosis	0.00028	0.00122	CcSEcCtD
Zafirlukast—Insomnia—Estradiol—osteoporosis	0.000278	0.00121	CcSEcCtD
Zafirlukast—Vomiting—Pamidronate—osteoporosis	0.000277	0.00121	CcSEcCtD
Zafirlukast—Asthenia—Conjugated Estrogens—osteoporosis	0.000275	0.0012	CcSEcCtD
Zafirlukast—Rash—Pamidronate—osteoporosis	0.000275	0.0012	CcSEcCtD
Zafirlukast—Dermatitis—Pamidronate—osteoporosis	0.000275	0.00119	CcSEcCtD
Zafirlukast—Headache—Pamidronate—osteoporosis	0.000273	0.00119	CcSEcCtD
Zafirlukast—Diarrhoea—Zoledronate—osteoporosis	0.000273	0.00119	CcSEcCtD
Zafirlukast—Nausea—Risedronate—osteoporosis	0.000273	0.00119	CcSEcCtD
Zafirlukast—Pruritus—Conjugated Estrogens—osteoporosis	0.000272	0.00118	CcSEcCtD
Zafirlukast—Dyspepsia—Estradiol—osteoporosis	0.00027	0.00118	CcSEcCtD
Zafirlukast—Gastrointestinal disorder—Estradiol—osteoporosis	0.000265	0.00115	CcSEcCtD
Zafirlukast—Fatigue—Estradiol—osteoporosis	0.000265	0.00115	CcSEcCtD
Zafirlukast—Dizziness—Zoledronate—osteoporosis	0.000264	0.00115	CcSEcCtD
Zafirlukast—Pain—Estradiol—osteoporosis	0.000263	0.00114	CcSEcCtD
Zafirlukast—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000263	0.00114	CcSEcCtD
Zafirlukast—Nausea—Pamidronate—osteoporosis	0.000259	0.00113	CcSEcCtD
Zafirlukast—Dizziness—Conjugated Estrogens—osteoporosis	0.000254	0.0011	CcSEcCtD
Zafirlukast—Vomiting—Zoledronate—osteoporosis	0.000253	0.0011	CcSEcCtD
Zafirlukast—Feeling abnormal—Estradiol—osteoporosis	0.000253	0.0011	CcSEcCtD
Zafirlukast—Rash—Zoledronate—osteoporosis	0.000251	0.00109	CcSEcCtD
Zafirlukast—Gastrointestinal pain—Estradiol—osteoporosis	0.000251	0.00109	CcSEcCtD
Zafirlukast—Dermatitis—Zoledronate—osteoporosis	0.000251	0.00109	CcSEcCtD
Zafirlukast—Headache—Zoledronate—osteoporosis	0.00025	0.00109	CcSEcCtD
Zafirlukast—Vomiting—Conjugated Estrogens—osteoporosis	0.000244	0.00106	CcSEcCtD
Zafirlukast—Urticaria—Estradiol—osteoporosis	0.000244	0.00106	CcSEcCtD
Zafirlukast—Abdominal pain—Estradiol—osteoporosis	0.000243	0.00106	CcSEcCtD
Zafirlukast—Body temperature increased—Estradiol—osteoporosis	0.000243	0.00106	CcSEcCtD
Zafirlukast—Rash—Conjugated Estrogens—osteoporosis	0.000242	0.00105	CcSEcCtD
Zafirlukast—Dermatitis—Conjugated Estrogens—osteoporosis	0.000242	0.00105	CcSEcCtD
Zafirlukast—Headache—Conjugated Estrogens—osteoporosis	0.00024	0.00105	CcSEcCtD
Zafirlukast—Nausea—Zoledronate—osteoporosis	0.000237	0.00103	CcSEcCtD
Zafirlukast—Nausea—Conjugated Estrogens—osteoporosis	0.000228	0.000991	CcSEcCtD
Zafirlukast—Hypersensitivity—Estradiol—osteoporosis	0.000226	0.000984	CcSEcCtD
Zafirlukast—Asthenia—Estradiol—osteoporosis	0.00022	0.000958	CcSEcCtD
Zafirlukast—Pruritus—Estradiol—osteoporosis	0.000217	0.000945	CcSEcCtD
Zafirlukast—Diarrhoea—Estradiol—osteoporosis	0.00021	0.000914	CcSEcCtD
Zafirlukast—Dizziness—Estradiol—osteoporosis	0.000203	0.000883	CcSEcCtD
Zafirlukast—Vomiting—Estradiol—osteoporosis	0.000195	0.000849	CcSEcCtD
Zafirlukast—Rash—Estradiol—osteoporosis	0.000194	0.000842	CcSEcCtD
Zafirlukast—Dermatitis—Estradiol—osteoporosis	0.000194	0.000841	CcSEcCtD
Zafirlukast—Headache—Estradiol—osteoporosis	0.000192	0.000836	CcSEcCtD
Zafirlukast—Nausea—Estradiol—osteoporosis	0.000182	0.000793	CcSEcCtD
Zafirlukast—CYSLTR2—Signaling Pathways—ESR1—osteoporosis	5.1e-05	0.000794	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—MGLL—osteoporosis	5.06e-05	0.000789	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—GPD2—osteoporosis	4.99e-05	0.000778	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—PGLS—osteoporosis	4.99e-05	0.000778	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	4.99e-05	0.000778	CbGpPWpGaD
Zafirlukast—CYP3A4—Phase 1 - Functionalization of compounds—POMC—osteoporosis	4.88e-05	0.00076	CbGpPWpGaD
Zafirlukast—CYP2C8—Biological oxidations—POMC—osteoporosis	4.83e-05	0.000752	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	4.78e-05	0.000744	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	4.78e-05	0.000744	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—IRS1—osteoporosis	4.76e-05	0.000742	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—POMC—osteoporosis	4.59e-05	0.000715	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—ATIC—osteoporosis	4.57e-05	0.000711	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—PNP—osteoporosis	4.57e-05	0.000711	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—PKM—osteoporosis	4.55e-05	0.000709	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—FDPS—osteoporosis	4.55e-05	0.000709	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—IDH2—osteoporosis	4.48e-05	0.000698	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—IL6R—osteoporosis	4.48e-05	0.000697	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	4.46e-05	0.000694	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—IGF1—osteoporosis	4.41e-05	0.000687	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—ADCY5—osteoporosis	4.32e-05	0.000673	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—PGLS—osteoporosis	4.32e-05	0.000672	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—GPD2—osteoporosis	4.32e-05	0.000672	CbGpPWpGaD
Zafirlukast—CYP3A4—Biological oxidations—CYP19A1—osteoporosis	4.31e-05	0.000672	CbGpPWpGaD
Zafirlukast—CYP2C19—Biological oxidations—POMC—osteoporosis	4.31e-05	0.000671	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—IDH2—osteoporosis	4.31e-05	0.000671	CbGpPWpGaD
Zafirlukast—CYP3A4—Metapathway biotransformation—CYP19A1—osteoporosis	4.25e-05	0.000662	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—CYP27A1—osteoporosis	4.21e-05	0.000656	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—SPP1—osteoporosis	4.18e-05	0.000652	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—ACP5—osteoporosis	4.1e-05	0.000639	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	4.08e-05	0.000636	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—PKM—osteoporosis	4.06e-05	0.000633	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—FDPS—osteoporosis	4.06e-05	0.000633	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	4.06e-05	0.000633	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—CYP27A1—osteoporosis	4.05e-05	0.000631	CbGpPWpGaD
Zafirlukast—CYP2D6—Biological oxidations—POMC—osteoporosis	3.96e-05	0.000617	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—ATIC—osteoporosis	3.95e-05	0.000615	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—PNP—osteoporosis	3.95e-05	0.000615	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—ACP5—osteoporosis	3.94e-05	0.000613	CbGpPWpGaD
Zafirlukast—CYP2C9—Biological oxidations—POMC—osteoporosis	3.93e-05	0.000612	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	3.89e-05	0.000606	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—OXCT1—osteoporosis	3.88e-05	0.000605	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—CA2—osteoporosis	3.88e-05	0.000605	CbGpPWpGaD
Zafirlukast—ABCG2—Transmembrane transport of small molecules—ADCY5—osteoporosis	3.86e-05	0.000601	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—GPD2—osteoporosis	3.85e-05	0.0006	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—PGLS—osteoporosis	3.85e-05	0.0006	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—TPI1—osteoporosis	3.81e-05	0.000594	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—MGLL—osteoporosis	3.78e-05	0.000589	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—IRS2—osteoporosis	3.78e-05	0.000589	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—FDPS—osteoporosis	3.74e-05	0.000582	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—PKM—osteoporosis	3.74e-05	0.000582	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—PKM—osteoporosis	3.71e-05	0.000577	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—FDPS—osteoporosis	3.71e-05	0.000577	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—LEP—osteoporosis	3.7e-05	0.000577	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—TPI1—osteoporosis	3.66e-05	0.00057	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—P4HB—osteoporosis	3.58e-05	0.000558	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—GPD2—osteoporosis	3.54e-05	0.000552	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—PGLS—osteoporosis	3.54e-05	0.000552	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—ESR1—osteoporosis	3.53e-05	0.00055	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—ATIC—osteoporosis	3.52e-05	0.000549	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—PNP—osteoporosis	3.52e-05	0.000549	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—GAPDH—osteoporosis	3.52e-05	0.000548	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—PGLS—osteoporosis	3.51e-05	0.000547	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—GPD2—osteoporosis	3.51e-05	0.000547	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	3.47e-05	0.000541	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—P4HB—osteoporosis	3.44e-05	0.000536	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—RAP1A—osteoporosis	3.43e-05	0.000534	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—GAPDH—osteoporosis	3.38e-05	0.000526	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling by GPCR—IL6—osteoporosis	3.38e-05	0.000526	CbGpPWpGaD
Zafirlukast—CYP1A2—Biological oxidations—POMC—osteoporosis	3.36e-05	0.000523	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—OXCT1—osteoporosis	3.36e-05	0.000523	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—CA2—osteoporosis	3.36e-05	0.000523	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—IRS1—osteoporosis	3.3e-05	0.000514	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—RAP1A—osteoporosis	3.29e-05	0.000513	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—MGLL—osteoporosis	3.27e-05	0.00051	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—ATIC—osteoporosis	3.24e-05	0.000505	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—PNP—osteoporosis	3.24e-05	0.000505	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—IDH2—osteoporosis	3.22e-05	0.000501	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—PNP—osteoporosis	3.21e-05	0.0005	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—ATIC—osteoporosis	3.21e-05	0.0005	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—POMC—osteoporosis	3.18e-05	0.000495	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—PKM—osteoporosis	3.17e-05	0.000493	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—FDPS—osteoporosis	3.17e-05	0.000493	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—IL6R—osteoporosis	3.1e-05	0.000483	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	3.08e-05	0.00048	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—IGF1—osteoporosis	3.06e-05	0.000476	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—CYP27A1—osteoporosis	3.03e-05	0.000471	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—PGLS—osteoporosis	3e-05	0.000468	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—GPD2—osteoporosis	3e-05	0.000468	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—CA2—osteoporosis	3e-05	0.000467	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—OXCT1—osteoporosis	3e-05	0.000467	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—ACP5—osteoporosis	2.94e-05	0.000458	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—MGLL—osteoporosis	2.92e-05	0.000455	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism of lipids and lipoproteins—POMC—osteoporosis	2.87e-05	0.000447	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—IDH2—osteoporosis	2.78e-05	0.000433	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—ENO1—osteoporosis	2.77e-05	0.000431	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—OXCT1—osteoporosis	2.76e-05	0.000429	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—CA2—osteoporosis	2.76e-05	0.000429	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	2.75e-05	0.000429	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—ATIC—osteoporosis	2.75e-05	0.000428	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—PNP—osteoporosis	2.75e-05	0.000428	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—TPI1—osteoporosis	2.74e-05	0.000426	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—OXCT1—osteoporosis	2.73e-05	0.000426	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—CA2—osteoporosis	2.73e-05	0.000426	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—PSMA2—osteoporosis	2.73e-05	0.000425	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—PSMA5—osteoporosis	2.73e-05	0.000425	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—MGLL—osteoporosis	2.69e-05	0.000418	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—MGLL—osteoporosis	2.66e-05	0.000415	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—ENO1—osteoporosis	2.66e-05	0.000414	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—MYC—osteoporosis	2.65e-05	0.000413	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—TGFB1—osteoporosis	2.65e-05	0.000412	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—PSMA5—osteoporosis	2.62e-05	0.000408	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—PSMA2—osteoporosis	2.62e-05	0.000408	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—CYP27A1—osteoporosis	2.62e-05	0.000407	CbGpPWpGaD
Zafirlukast—CYP3A4—Biological oxidations—POMC—osteoporosis	2.59e-05	0.000404	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—P4HB—osteoporosis	2.57e-05	0.000401	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—ACP5—osteoporosis	2.54e-05	0.000396	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—GAPDH—osteoporosis	2.53e-05	0.000393	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	2.51e-05	0.000391	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	2.51e-05	0.000391	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—IDH2—osteoporosis	2.48e-05	0.000387	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—RAP1A—osteoporosis	2.46e-05	0.000383	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—PKM—osteoporosis	2.44e-05	0.000381	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—FDPS—osteoporosis	2.44e-05	0.000381	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—TPI1—osteoporosis	2.37e-05	0.000368	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling by GPCR—IL6—osteoporosis	2.34e-05	0.000364	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—CA2—osteoporosis	2.33e-05	0.000364	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—OXCT1—osteoporosis	2.33e-05	0.000364	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—CYP27A1—osteoporosis	2.33e-05	0.000364	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—PGLS—osteoporosis	2.32e-05	0.000361	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—GPD2—osteoporosis	2.32e-05	0.000361	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—IDH2—osteoporosis	2.28e-05	0.000356	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—MGLL—osteoporosis	2.28e-05	0.000354	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—ACP5—osteoporosis	2.27e-05	0.000354	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—IDH2—osteoporosis	2.26e-05	0.000353	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	2.24e-05	0.000349	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—P4HB—osteoporosis	2.22e-05	0.000346	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—CYP19A1—osteoporosis	2.21e-05	0.000345	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—GAPDH—osteoporosis	2.18e-05	0.00034	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—CYP27A1—osteoporosis	2.15e-05	0.000334	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	2.15e-05	0.000334	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—CYP27A1—osteoporosis	2.13e-05	0.000332	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—CYP19A1—osteoporosis	2.13e-05	0.000331	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—RAP1A—osteoporosis	2.13e-05	0.000331	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—ATIC—osteoporosis	2.12e-05	0.00033	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—PNP—osteoporosis	2.12e-05	0.00033	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—TPI1—osteoporosis	2.11e-05	0.000329	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—ACP5—osteoporosis	2.09e-05	0.000325	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—ACP5—osteoporosis	2.07e-05	0.000322	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	2.04e-05	0.000318	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—IL6—osteoporosis	1.99e-05	0.000311	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—ENO1—osteoporosis	1.99e-05	0.00031	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—P4HB—osteoporosis	1.98e-05	0.000309	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—PSMA2—osteoporosis	1.96e-05	0.000305	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—PSMA5—osteoporosis	1.96e-05	0.000305	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—GAPDH—osteoporosis	1.95e-05	0.000303	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—TPI1—osteoporosis	1.94e-05	0.000302	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—IDH2—osteoporosis	1.93e-05	0.000301	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—TPI1—osteoporosis	1.92e-05	0.0003	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—RAP1A—osteoporosis	1.9e-05	0.000296	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism of lipids and lipoproteins—POMC—osteoporosis	1.85e-05	0.000289	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—MYC—osteoporosis	1.84e-05	0.000286	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—TGFB1—osteoporosis	1.83e-05	0.000286	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—P4HB—osteoporosis	1.83e-05	0.000284	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—CYP27A1—osteoporosis	1.82e-05	0.000283	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—P4HB—osteoporosis	1.81e-05	0.000282	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—ADCY5—osteoporosis	1.81e-05	0.000282	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—GPX1—osteoporosis	1.8e-05	0.000281	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—OXCT1—osteoporosis	1.8e-05	0.000281	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—CA2—osteoporosis	1.8e-05	0.000281	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—GAPDH—osteoporosis	1.79e-05	0.000279	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—GAPDH—osteoporosis	1.78e-05	0.000277	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—ACP5—osteoporosis	1.77e-05	0.000276	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—MGLL—osteoporosis	1.76e-05	0.000273	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	1.75e-05	0.000272	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—RAP1A—osteoporosis	1.75e-05	0.000272	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—ADCY5—osteoporosis	1.74e-05	0.000271	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—GPX1—osteoporosis	1.73e-05	0.00027	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—RAP1A—osteoporosis	1.73e-05	0.000269	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—ENO1—osteoporosis	1.72e-05	0.000268	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—PSMA2—osteoporosis	1.69e-05	0.000264	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—PSMA5—osteoporosis	1.69e-05	0.000264	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—MTHFR—osteoporosis	1.66e-05	0.000259	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism of lipids and lipoproteins—POMC—osteoporosis	1.65e-05	0.000258	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—TPI1—osteoporosis	1.64e-05	0.000256	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—MTHFR—osteoporosis	1.6e-05	0.000249	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—CYP19A1—osteoporosis	1.59e-05	0.000248	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—P4HB—osteoporosis	1.55e-05	0.000241	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—ENO1—osteoporosis	1.53e-05	0.000239	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—GAPDH—osteoporosis	1.52e-05	0.000236	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—PSMA2—osteoporosis	1.51e-05	0.000235	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—PSMA5—osteoporosis	1.51e-05	0.000235	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism of lipids and lipoproteins—POMC—osteoporosis	1.51e-05	0.000235	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—IDH2—osteoporosis	1.49e-05	0.000233	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—RAP1A—osteoporosis	1.48e-05	0.00023	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—ENO1—osteoporosis	1.41e-05	0.00022	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—CYP27A1—osteoporosis	1.4e-05	0.000219	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—ENO1—osteoporosis	1.4e-05	0.000218	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—PSMA5—osteoporosis	1.39e-05	0.000217	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—PSMA2—osteoporosis	1.39e-05	0.000217	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—IL6—osteoporosis	1.38e-05	0.000215	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—PSMA2—osteoporosis	1.38e-05	0.000215	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—PSMA5—osteoporosis	1.38e-05	0.000215	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—CYP19A1—osteoporosis	1.37e-05	0.000214	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—ACP5—osteoporosis	1.37e-05	0.000213	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—POMC—osteoporosis	1.33e-05	0.000207	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—ADCY5—osteoporosis	1.3e-05	0.000202	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—GPX1—osteoporosis	1.29e-05	0.000202	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism of lipids and lipoproteins—POMC—osteoporosis	1.29e-05	0.000201	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—POMC—osteoporosis	1.28e-05	0.000199	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—TPI1—osteoporosis	1.27e-05	0.000198	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—CYP19A1—osteoporosis	1.23e-05	0.000191	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—ENO1—osteoporosis	1.2e-05	0.000186	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—MTHFR—osteoporosis	1.19e-05	0.000186	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—P4HB—osteoporosis	1.19e-05	0.000186	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—PSMA2—osteoporosis	1.18e-05	0.000183	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—PSMA5—osteoporosis	1.18e-05	0.000183	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—GAPDH—osteoporosis	1.17e-05	0.000182	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—RAP1A—osteoporosis	1.14e-05	0.000178	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—CYP19A1—osteoporosis	1.13e-05	0.000176	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—ADCY5—osteoporosis	1.12e-05	0.000175	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—GPX1—osteoporosis	1.12e-05	0.000174	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—CYP19A1—osteoporosis	1.12e-05	0.000174	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—MTHFR—osteoporosis	1.03e-05	0.000161	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—ADCY5—osteoporosis	1e-05	0.000156	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—GPX1—osteoporosis	9.99e-06	0.000156	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—CYP19A1—osteoporosis	9.55e-06	0.000149	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—POMC—osteoporosis	9.55e-06	0.000149	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—ENO1—osteoporosis	9.22e-06	0.000144	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—ADCY5—osteoporosis	9.22e-06	0.000144	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—MTHFR—osteoporosis	9.21e-06	0.000144	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—GPX1—osteoporosis	9.18e-06	0.000143	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—ADCY5—osteoporosis	9.14e-06	0.000142	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—GPX1—osteoporosis	9.1e-06	0.000142	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—PSMA2—osteoporosis	9.09e-06	0.000142	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—PSMA5—osteoporosis	9.09e-06	0.000142	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—MTHFR—osteoporosis	8.48e-06	0.000132	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—MTHFR—osteoporosis	8.4e-06	0.000131	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—POMC—osteoporosis	8.26e-06	0.000129	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—ADCY5—osteoporosis	7.81e-06	0.000122	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—GPX1—osteoporosis	7.78e-06	0.000121	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—CYP19A1—osteoporosis	7.37e-06	0.000115	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—POMC—osteoporosis	7.37e-06	0.000115	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—MTHFR—osteoporosis	7.18e-06	0.000112	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—POMC—osteoporosis	6.78e-06	0.000106	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—POMC—osteoporosis	6.72e-06	0.000105	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—ADCY5—osteoporosis	6.03e-06	9.38e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—GPX1—osteoporosis	6e-06	9.35e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—POMC—osteoporosis	5.74e-06	8.94e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—MTHFR—osteoporosis	5.54e-06	8.63e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—POMC—osteoporosis	4.43e-06	6.9e-05	CbGpPWpGaD
